# National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients

> **NCT04086290** · PHASE1,PHASE2 · RECRUITING · sponsor: **Peter Busch Østergren** · enrollment: 20 (estimated)

## Conditions studied

- Prostate Cancer Metastatic

## Interventions

- **PROCEDURE:** RARP
- **RADIATION:** SBRT
- **DRUG:** ADT

## Key facts

- **NCT ID:** NCT04086290
- **Lead sponsor:** Peter Busch Østergren
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-10-10
- **Primary completion:** 2023-10
- **Final completion:** 2028-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04086290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04086290, "National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04086290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*